Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid
This study is ongoing, but not recruiting participants.
Study NCT00437450   Information provided by Groupe Francophone des Myelodysplasies
First Received: February 19, 2007   Last Updated: November 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia in Myelodysplastic Syndromes
Additional conditions recognized in this trial
Anemia
Myelodysplastic Syndromes
Preleukemia
Syndrome
More general conditions related to this trial
Bone Marrow Diseases
Disease
Hematologic Diseases
Neoplasms
Pathologic Processes
Precancerous Conditions
Interventions listed in this trial
Epoetin/Atra
Additional drug interventions recognized in this trial
Tretinoin
More general drug interventions related to this trial
Antineoplastic Agents
Dermatologic Agents
Keratolytic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Groupe Francophone des Myelodysplasies


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services